232 results
Keyword Vancomycin Remove keyword
-
List item
Referral: Vancomycin-containing medicines
vancomycin, Article 31 referrals
Status: European Commission final decision, opinion/position date: 18/05/2017, EC decision date: 21/09/2017, Last updated: 17/11/2017Vancomycin-containing medicines … prescribing information for vancomycin antibiotics … Vancomycin Article 31-1440 30 … -
List item
Opinion/decision on a Paediatric investigation plan (PIP): Vancomycin
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Infectious diseases
PIP number: EMEA-001311-PIP01-12-M01, Route(s) of administration: Intravenous use, Pharmaceutical form(s): Powder for concentrate for solution for infusion
Decision date: 26/01/2016, Last updated: 26/03/2016, Compliance check: XKey facts Vancomycin Infectious diseasesP/0026/2016EMEA-001311-PIP01-12-M01 … paediatric investigation plan for vancomycin (EMEA-001311-PIP01-12-01-M01 … paediatric investigation plan for vancomycin (EMEA-001311-PIP01-12-01-M01 … -
List item
Press release: EMA recommends changes to prescribing information for vancomycin antibiotics
CHMP, Last updated: 19/05/2017prescribing information for vancomycin antibiotics … information for the antibiotic vancomycin to ensure appropriate use … by Gram-positive bacteria. Vancomycin has been used since the 1950s … -
List item
Human medicine European public assessment report (EPAR): Tenkasi (previously Orbactiv)
oritavancin diphosphate, Soft Tissue Infections; Skin Diseases, Bacterial
Date of authorisation: 18/03/2015, Revision: 11, Authorised, Last updated: 16/09/2021to 10-day treatment with vancomycin (another glycopeptide) in … at least as effective as vancomycin at treating the infection … of patients treated with vancomycin. In addition, 82.7% of patients … -
List item
Human medicine European public assessment report (EPAR): Dificlir
fidaxomicin, Clostridium Infections
Date of authorisation: 05/12/2011, Revision: 17, Authorised, Last updated: 22/12/2022at least as effective as vancomycin (another antibiotic for … to Compare the Efficacy of Vancomycin Therapy to Extended Duration … compared with standard vancomycin therapy, language on extended … -
List item
Human medicine European public assessment report (EPAR): Zinforo
Ceftaroline fosamil, Community-Acquired Infections; Skin Diseases, Infectious; Pneumonia
Date of authorisation: 22/08/2012, Revision: 26, Authorised, Last updated: 22/07/2022receiving the combination of vancomycin and aztreonam (297 out of … receiving the combination of vancomycin and aztreonam (289 out of … with 87% of those receiving vancomycin or cefazolin, with or without … -
List item
Human medicine European public assessment report (EPAR): Quofenix
delafloxacin meglumine, Community-Acquired Infections
Date of authorisation: 16/12/2019,, Revision: 5, Authorised, Last updated: 13/10/2022
a vein was compared with vancomycin plus aztreonam (two other … of patients treated with vancomycin and aztreonam. In the second … by mouth was compared with vancomycin plus aztreonam given into … -
List item
Human medicine European public assessment report (EPAR): Xydalba
dalbavancin hydrochloride, Soft Tissue Infections; Skin Diseases, Bacterial
Date of authorisation: 19/02/2015, Revision: 15, Authorised, Last updated: 14/12/2022Xydalba was compared with vancomycin (another glycopeptide) or … MRSA. Patients who received vancomycin and responded to treatment … at least as effective as vancomycin or linezolid at curing the … -
List item
Human medicine European public assessment report (EPAR): Tygacil
Tigecycline, Bacterial Infections; Skin Diseases, Bacterial; Soft Tissue Infections
Date of authorisation: 24/04/2006, Revision: 34, Authorised, Last updated: 11/10/2022compared with the combination of vancomycin and aztreonam in 1,129 patients … around 89% of those receiving vancomycin and aztreonam. In the studies … -
List item
Human medicine European public assessment report (EPAR): Cubicin
daptomycin, Gram-Positive Bacterial Infections; Bacteremia; Soft Tissue Infections; Endocarditis, Bacterial
Date of authorisation: 19/01/2006, Revision: 37, Authorised, Last updated: 15/12/2022use of antibiotics such as vancomycin, a penicillin (including oxacillin … use of antibiotics such as vancomycin, a penicillin (including oxacillin … -
List item
News: Comments invited on reflection paper on risk of antimicrobial resistance transfer from companion animals to humans
CVMP, Last updated: 21/10/2013Staphylococcus pseudintermedius , vancomycin-resistant enterococci, extended-spectrum … Staphylococcus pseudintermedius, vancomycin-resistant enterococci, extended-spectrum … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 29 March - 1 April 2016
CHMP, Last updated: 01/04/2016Review on vancomycin … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 15-18 May 2017
CHMP, Last updated: 19/05/2017vancomycin antibiotics … -
List item
Referral: Targocid and associated names
teicoplanin, associated names: Targocid, Teicomid, Article 30 referrals
Status: European Commission final decision, opinion/position date: 30/05/2013, EC decision date: 12/09/2013, Last updated: 03/01/2014allergic to another antibiotic, vancomycin, as they may be at greater … allergic to another antibiotic, vancomycin, as they may be at greater … -
List item
Press release: European Medicines Agency recommends authorisation of novel antibiotic agent
CHMP, Last updated: 23/09/2011difficile are available, with vancomycin and metronidazole being linked … Dificlir is as effective as vancomycin in curing C. difficile infection … difficile are available, with vancomycin and metronidazole being … -
List item
Quality of medicines questions and answers: Part 1
Last updated: 05/02/2020 -
List item
National expert: Wei Zhao, European Medicines Agency (updated)
- Declaration of interests - 79.87 KB | PDF
- Curriculum Vitae - 34.35 KB | PDF
Renal Markers to Estimate Vancomycin Clearance in Critically … venovenous hemofiltration on vancomycin trough concentrations in … Therapeutic Drug Monitoring of Vancomycin: 2020 Update by the Division … -
List item
National expert: Karin Janssen van Doorn, Federal Agency for Medicines and Health Products (updated)
- Declaration of interests - 79.87 KB | PDF
- Curriculum Vitae - 21.12 KB | PDF
with continuous infusion of vancomycin in critically ill patients … M/1260/0080: Linezolid vs. Vancomycin/Oxacillin/Dicloxacillin in the treatment of catheter-related … -
List item
National expert: Marie-Laure Veyries, National Agency For The Safety Of Medicine And Health Products (updated)
- Declaration of interests - 79.78 KB | PDF
- Curriculum Vitae - 20.92 KB | PDF
quot;Controlled release of vancomycin from injectable poloxamer … quot;Prophylactic activity of vancomycin combined to a gel matrix … FAURISSON, G. COUARRAZE, et al. : "Vancomycin delivery from a poloxamer gel … -
List item
National expert: VERONICA GARCIA GIL, Spanish Agency of Medicines and Medical Devices (updated)
- Declaration of interests - 79.79 KB | PDF
- Curriculum Vitae - 17.87 KB | PDF
Oct 21. - Linezolid and vancomycin-resistant Enterococcus faecium peritonitis … -
List item
National expert: Emilia Cercenado Mansilla, Spanish Agency of Medicines and Medical Devices (updated)
- Declaration of interests - 80.77 KB | PDF
- Curriculum Vitae - 247.46 KB | PDF
-
List item
National expert: Camille Schurtz, National Agency For The Safety Of Medicine And Health Products (updated)
- Declaration of interests - 79.82 KB | PDF
- Curriculum Vitae - 18.88 KB | PDF
Suivi therapeutique de la vancomycine sans adaptation de la dose … Therapeutique pour un Bon Usage de la Vancomycine a l'hopital Saint Louis … Suivi therapeutique de la vancomycine sans adaptation de la dose … -
List item
National expert: Ivica Malnar, Agency for Medicinal Products and Medical Devices of Croatia (updated)
- Declaration of interests - 79.8 KB | PDF
- Curriculum Vitae - 22.27 KB | PDF
bis-diaryl ether fragment of vancomycin via enzymatic oxidative phenolic … didechloroaglucovancomycin and vancomycin" J. Mol. Catal. B: Enzymatic … -
List item
Orphan designation: (E)-(6-((N-methyl-((3-methylbenzofuran-2-yl)methyl)amino)-3-oxoprop-1-en-1-yl)-2-oxo-3,4-dihydro-1,8-naphthyridin-1(2H)-yl)methyl phosphate, bis ethanolamine salt (afabicin) for: Treatment of osteomyelitis
Date of designation: 14/10/2016, Positive, Last updated: 13/10/2021infectious osteomyelitis. Vancomycin was one of the antibiotics … infectious osteomyelitis. Vancomycin was one of the antibiotics … -
List item
National expert: Luisa Vieira Peixe, European Medicines Agency (updated)
- Declaration of interests - 79.9 KB | PDF
- Curriculum Vitae - 23.68 KB | PDF